RECENTLY RELEASED CORONAVIRUS RELATED ARTICLES AND BLOGS ACCORDING TO DISEASE APPROACH. August 2020

Warning: Disseminating results by press release — instead of via peer- reviewed publication — can be misused to manipulate public reaction, generate funding or hide critical information.

BASED ON PFG August Newsletter DIAGNOSTIC FDA authorizes first tests for measuring COVID-19 antibody amount. Fierce Biotech Where is the money for COVID-19 diagnostics? Devex The breakthrough that could halt the pandemic, even before a vaccine. Politico Coronavirus: Ten African innovations to help tackle Covid-19. BBC Game-changing COVID-19 Saliva Test Receives Regulatory Approval In The United States. Health Policy Watch The Science Behind Saliva-Based Rapid Diagnostic Testing. Technology Networks Qiagen to launch digital, portable test for COVID-19 antibodies, preordering 900K for U.S.. Fierce Biotech In ‘milestone,’ FDA OKs simple, accurate coronavirus test that could cost just $5. Science

TREATMENT Next big COVID-19 treatment may be manufactured antibodies. Reuters Exploring Drug Repurposing for COVID-19 Treatment. NIH Director’s Blog Designer antibodies could battle COVID-19 before vaccines arrive. Science Tiziana Life Sciences Announces an Expedited Clinical Development Plan for Its Anti-Interleukin-6-Receptor, a Fully Human Monoclonal Antibody, for the Treatment of COVID-19 Patients. Biospace Statement from Yale Faculty on Hydroxychloroquine and its Use in COVID- 19. Medium Regeneron says antibody cocktail prevents and treats COVID-19 in animals. Reuters Covid-19 Researchers Hope Monoclonal Antibody Treatments Are a Bridge to Vaccine. The Wall Street Journal Yes, we need a vaccine to control Covid-19. But we need new treatments, too. STAT

Hydroxychloroquine RCTs: 'Ethically, the Choice Is Clear'. Medscape AI invents new ‘recipes’ for potential COVID-19 drugs. Science Antibody therapies could be a bridge to a coronavirus vaccine — but will the world benefit?. Nature Pfizer signs up to help manufacture Gilead's scarce coronavirus-fighter remdesivir. FiercePharma IAVI and Wellcome Issue a Global Call to Action: Monoclonal Antibodies for COVID-19 and Other Diseases Could Save Millions of Lives. Businesswire In Race to Develop Covid-19 Medicines, Investors Urge Pharma Cos to Put People Ahead of Profits. ICCR Malaria Research Accelerates Coronavirus Vaccine Development. The Indian Wire Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats. Business Wire Antibody drugs could be one of the best weapons against Covid-19. But will they matter?. STAT Efficacy of Remdesivir in COVID-19. JAMA Editorial Six of the most promising treatments for Covid-19 so far. Urged on by scientists, NIH will study Gilead’s remdesivir-like compound against Covid-19. STAT AstraZeneca doses first participants in phase 1 clinical trial for COVID-19 treatment. Homeland Preparedness News Expanding access to monoclonal antibody-based products: A global call to action These promising coronavirus treatments are saving lives. National Geographic Margaret McCartney: We need better evidence on non-drug interventions for covid-19. BMJ Blog Anti-covid-19 medicines are being approved too easily. The Economist Vir and GlaxoSmithKline begin pivotal study of Covid-19 antibody drug. STAT

Race for a VACCINE Russia preparing mass vaccination against coronavirus for October. Reuters Scientists Worry About Political Influence Over Coronavirus Vaccine Project. The New York Times

Russia claims to be ahead of rivals in race to produce Covid vaccine. The Guardian Novavax’s Covid-19 vaccine shows promising immune response, early data show. STAT Scientists are working to fast-forward COVID-19 research, but not at the expense of ethics. BHEKISISA The rush to create a covid-19 vaccine may do more harm than good. BMJ Opinion Covid-19: Where are we on immunity and vaccines?. BMJ News Covid-19 Vaccine Trials Have a Problem: Minority Groups Don’t Trust Them. The Wall Street Journal Exclusive: Fauci says regulators promise politics will not guide vaccine timing. Reuters Nation’s Leading Vaccine Authorities Urge Thorough Review of Safety and Efficacy of COVID-19 Vaccines. Center for Science in the Public Interest WHO says the late-stage coronavirus trials don’t mean a vaccine is ‘nearly there’. CNBC Moderna Backtracks to Open Covid Vaccine Trial to Those With HIV. Bloomberg Covid-19: lack of diversity threatens to undermine vaccine trials, experts warn. The Guardian Cutting Corners in the Race for a Vaccine. Spiegel This Company Boasted to Trump About Its Covid-19 Vaccine. Experts Are Skeptical.. The New York Times COVID-19: HHS explains “Operation Warp Speed”. Science Speaks The Russian Vaccine. Science Russia approves Sputnik V Covid vaccine despite testing safety concerns. The Guardian ‘This Is All Beyond Stupid.’ Experts Worry About Russia’s Rushed Vaccine. The New York Times Russia’s Rapid COVID-19 Vaccine Approval Draws Intense Criticism From Some – And Offers To Collaborate From Others. Health Policy Watch Draft landscape of COVID-19 candidate vaccines. WHO Russia is Rapid COVID-19 Vaccine Approval Draws Intense Criticism From Some – And Offers To Collaborate From Others. Health Policy Watch South Africa to take part in two more Covid-19 vaccine trials, with up to 12,000 volunteers. Daily Maverick Vaccine Dreams and Russian Reality. Think Global Health

Covid-19 vaccine trials have been slow to recruit Black and Latino people - - and that could delay a vaccine. CNN What the immune response to the coronavirus says about the prospects for a vaccine. Nature These are the top coronavirus vaccines to watch. The Washington Post Novavax begins mid-stage study of COVID-19 vaccine in South Africa. Reuters WHO blasts 'vaccine nationalism' in last-ditch push against hoarding. Reuters The rush to create a covid-19 vaccine may do more harm than good. BMJ Covid Vaccine Turns Into a Shot at Redemption for Britain. Bloomberg England and Germany neck-and-neck in race to produce first vaccine. The Telegraph Pakistan gives go-ahead to Phase 3 COVID-19 vaccine trial. Reuters Modelling the Manufacturing Process for COVID-19 Vaccines: Our Approach. CGD COVID vaccine candidates: WHO lists 30 in clinical evaluation, six in phase 3. Science Speaks How to measure the success of a COVID-19 vaccine?. CEPI Coronavirus vaccine: Short cuts and allegations of dirty tricks in race to be first. BBC Phase 3 vaccine trials in the U.S. July 27-Aug. 20/21: A timeline. Science Speaks Coronavirus vaccines: We address 3 big questions about safety, distribution and adoption. Journalist Resource Coronavirus: China has been giving potential vaccine to key workers since July. The Guardian Cheat Sheet: COVID-19 Vaccine Pipeline. AVAC The unequal scramble for coronavirus vaccines — by the numbers. Nature Advocates’ Guide: The risks and benefits of expedited COVID-19 vaccine research. AVAC A Vaccine That Stops Covid-19 Won’t Be Enough. The New York Times Moderna COVID-19 vaccine appears to work as well in older adults in early study. Reuters COVID-19 vaccine trials should seek worthwhile efficacy. What if the First Coronavirus Vaccines Aren’t the Best?. The New York Times

Covid vaccine rush could make pandemic worse, say scientists. The Guardian

Vaccine ACCES GAVI’s new drive for COVID-19 vaccine access in LMIC countries includes India. Express Pharma GAVI COVAX AMC: African countries qualify for COVID-19 vaccines. African Science News Debate begins for who’s first in line for COVID-19 vaccine. AP GAVI in talks to make Indian vaccine makers join Covax: CEO Seth Berkley. Economic Times CEPI survey assesses potential COVID-19 vaccine manufacturing capacity. Most of Africa will not have access to Covid-19 vaccines for up to a year after approval. Quartz Africa Global report: WHO warns against dangers of 'vaccine nationalism'. The Guardian COVID-19 vaccine: Serum Institute signs deal with Gates Foundation; to price vaccine below ₹250/dose. LiveMint COVID-19 vaccine doses to be made available for low- and middle-income countries as early as 2021. GAVI India's Serum Institute to get $150 million from Gates Foundation for COVID-19 vaccine. Reuters Pandemic total passes 19 million, vaccine capacity ramps up for lower income countries. CIDRAP Landmark partnerships for Serum Institute of India to produce COVID-19 vaccines. The Pharma Letter “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley. Health Policy Watch Why Switzerland's Moderna Covid-19 vaccine deal is risky. Swiss Info Who would benefit from a successful Chinese COVID-19 vaccine?. The Hill Coronavirus: How will the world vaccinate seven billion?. BBC CEPI reserves manufacturing capacity for COVID-19 vaccines at SK bioscience. CEPI WHO chief calls for solidarity in financing, ensuring equal access to future COVID-19 vaccine. UN NEws This is how we can counteract vaccine nationalism. Wemos

Creating a COVID-19 vaccine is only the first step. It’ll take years to manufacture and distribute. The Conversation COVAX seeks civil society representatives to contribute to ensuring equitable global access to COVID-19 vaccines. CEPI Kenya Among 92 States Set to Get Cheap Covid-19 Vaccine. All Africa WHO lays out steps to prioritize covid vaccine distribution among countries. LiveMint Will Covid-19 vaccines be safe for children and pregnant women? The data, so far, are lacking. STAT A global COVID-19 facility could prevent 'vaccine nationalism' — but the challenges are steep. Devex Oxford University Covid-19 vaccine firm says it is not in talks with Trump. The Guardian 172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility. WHO India is key for global access to a COVID-19 vaccine – here’s why. The Conversation The Covax Exchange: Gavi’s plans to let countries trade in vaccines. Geneva Health Files Exclusive: WHO sweetens terms to join struggling global COVAX vaccine facility - documents. Reuters New reckoning for WHO vaccine plan as governments go it alone. Reuter Here’s how the U.S. could release a COVID-19 vaccine before the election— and why that scares some. Science When a COVID-19 Vaccine is Ready, The “COVAX Facility” Will Bring it to the World’s Population. UN Dispatch New COVID-19 Global Vaccine Facility Would Include Three-Track Finance Mechanism – But Finalizing Legal Structure Is Critical. Health Policy Watch

FUNDING/ Prices Ensuring Global Access To A COVID-19 Vaccine Will Require A Massive Dose Of Funding – But How Much Really?. Health Policy Watch Does Anyone Really Know How Much a COVID-19 Vaccine Will Cost Governments?. Newsweek The Gates Foundation Commits Another $150 Million to Accelerate Covid- 19 Vaccines. Barron’s

The Contributions Of The Gates Foundation Towards COVID-19 Vaccine To Reduce The Price Of The Vaccine And Make It Available For Poor Nations. Inventiva WHO calls on wealthy countries to support global Covid-19 vaccine scheme. Irish Times Bringing a COVID-19 Vaccine to Market: Where Do We Go from Here?. CGD Funding COVID-19 vaccines: A timeline. Devex Oxford’s COVID vaccine deal with AstraZeneca raises concerns about access and pricing. Fortune EU offers 400 million euros to WHO-led COVID-19 vaccine initiative. Reuters

OTHERS COVID19 related ISSUES Non-COVID Clinical Trials Grind to a Halt During Pandemic. Medscape Vaccine Nationalism Makes a Deadly Disease Even Worse. Bloomberg The pandemic appears to have spared Africa so far. Scientists are struggling to explain why. Science New six-month report flags growing number of medical product quality concerns relating to COVID-19. IDDO The covid-19 pandemic will be over by the end of 2021, says Bill Gates. The Economist Delivery mechanism: Waiting for vaccine, key players knock on India’s door for vials and syringes. Indian Express Research, innovation vital in new COVID-19 world. SciDevNet Preparing For the Vaccine Results. Science COVID-19 vaccines are getting closer. Should we be worried they've come so quickly?. ABC Australia Coronavirus vaccine questions answered. Will you need boosters? How long is immunity?. ABC Australia How to stop COVID-19 fuelling a resurgence of AIDS, malaria and tuberculosis. Nature Studies highlight dynamic impact of COVID-19 on antibiotic use. CIDRAP Pfizer, Moderna's coronavirus shot rollouts could freeze up, experts say, citing cold-storage needs. Fierce Pharma One shot of coronavirus vaccine likely won't be enough . CNN Moderna failed to disclose federal funding for vaccine patent applications, advocates say. STAT

In the World’s Coronavirus Blind Spot, Fears of a Silent Epidemic. The Wall Street Journal Emergency authorisation of COVID 19 vaccines needs great care: WHO . Reuters Opinion: We need to improve AMR surveillance systems, now more than ever. Devex Source: PFG August Newsletter